These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24837778)

  • 1. Response on letter by Arya et al.: "evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.".
    Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Qadri F; Lundgren A; Svennerholm AM; Sack DA
    Vaccine; 2014 Jul; 32(32):4014. PubMed ID: 24837778
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
    Arya SC; Agarwal N
    Vaccine; 2014 Jul; 32(32):4013. PubMed ID: 24831232
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
    Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Lundgren A; Sack DA; Svennerholm AM; Qadri F
    Vaccine; 2014 Feb; 32(9):1055-60. PubMed ID: 24440210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 5. Typhoid vaccines.
    Aggarwal A; Dutta AK
    Indian J Pediatr; 2001 Aug; 68(8):733-6. PubMed ID: 11563251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with live, oral Ty21a typhoid vaccine.
    Kaplan DT; Hill DR
    JAMA; 1992 Feb; 267(8):1074. PubMed ID: 1735924
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a.
    Wiedermann G
    J Travel Med; 1998 Mar; 5(1):1-2. PubMed ID: 9772307
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Typhoid fever: from parenteral to oral vaccines].
    Lopalco PL; Prato R; Germinario C
    Ann Ig; 2002; 14(3 Suppl 3):27-32. PubMed ID: 12389408
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Advisory Committee on Immunization (NACI). Supplementary statement on Typhim VI polysaccharide capsular vaccine.
    Can Commun Dis Rep; 1995 Nov; 21(22):197-200. PubMed ID: 8574205
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonspecific effects of oral vaccination with live-attenuated
    Pennington SH; Ferreira DM; Caamaño-Gutiérrez E; Reiné J; Hewitt C; Hyder-Wright AD; Gordon SB; Gordon MA
    Sci Adv; 2019 Feb; 5(2):eaau6849. PubMed ID: 30820452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of anaphylaxis to Typhoid Vaccine Live Oral Ty21a (Vivotif).
    Haas NL; Haas MRC; Gregory C
    J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses.
    Won G; Kim B; Lee JH
    Vaccine; 2017 Jun; 35(25):3333-3341. PubMed ID: 28495314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.